Today: 27 April 2026
Browse Category

Technology 7 January 2026

NIO stock ticks up as CATL battery-swap pact, millionth-vehicle milestone hit tape

NIO stock ticks up as CATL battery-swap pact, millionth-vehicle milestone hit tape

NIO shares rose 0.2% to $4.79 in early New York trading after announcing a five-year battery partnership with CATL. The company marked its 1,000,000th vehicle in Hefei and set new growth and infrastructure targets. CATL said the deal will focus on longer-life batteries and battery-swap technology. Financial terms and rollout timelines were not disclosed.
Micron stock in focus as $100B New York “megafab” groundbreaking gets a date

Micron stock in focus as $100B New York “megafab” groundbreaking gets a date

Micron will break ground on its $100 billion New York megafab Jan. 16, aiming to build the largest U.S. semiconductor facility. Shares slipped 0.1% to $342.97 in early Nasdaq trading. Investors are watching AI-driven memory pricing and Micron’s capital spending plans ahead of its next update. Broader chip stocks fell, with the iShares Semiconductor ETF down 0.9% Wednesday morning.
Intel stock today: INTC steadies before the bell as CES “Panther Lake” chips put 18A under the microscope

Intel stock today: INTC steadies before the bell as CES “Panther Lake” chips put 18A under the microscope

Intel shares were flat in premarket trading Wednesday after closing up 1.7% at $40.04. At CES, Intel launched its first 18A-built laptop chip, Panther Lake, promising 60% better performance over the previous model. The company said pre-orders for Core Ultra Series 3 laptops began Jan. 6, with global availability set for Jan. 27. Investors await Intel’s next earnings report on Jan. 29.
Ondas (ONDS) stock slides in premarket as Needham conference and share-sale filings hit the tape

Ondas (ONDS) stock slides in premarket as Needham conference and share-sale filings hit the tape

Ondas Holdings shares fell 3.5% to $12.39 premarket Wednesday after announcing CEO Eric Brock will speak at Needham’s Growth Conference on Jan. 14, ahead of a Jan. 16 investor day focused on its 2026 outlook. Recent SEC filings show insider sale plans and a prospectus registering 2.4 million shares for resale, raising questions about share supply. The stock closed Tuesday at $12.84, near its 52-week high.
7 January 2026
Sandisk stock rockets as Nvidia’s CES message revives the AI storage trade

Sandisk stock rockets as Nvidia’s CES message revives the AI storage trade

Sandisk surged 27.6% to $349.63 on Tuesday, leading a rally in U.S. memory stocks after CES comments spotlighted storage as a bottleneck for AI. NAND flash prices have doubled since July, with suppliers sold out through 2026. Sandisk has gained two points of NAND market share in the past year. Investors await its Jan. 29 earnings for updates on SSD pricing and strategy.
CES 2026 highlights: Nvidia’s Vera Rubin AI chips and humanoid robots push tech into the real world

CES 2026 highlights: Nvidia’s Vera Rubin AI chips and humanoid robots push tech into the real world

Nvidia CEO Jensen Huang announced at CES 2026 that Vera Rubin AI chips are in full production, promising a five-fold boost in AI computing. AMD previewed MI500 chips shipping in 2027, while Intel launched Panther Lake Core Ultra Series 3 PC chips with up to 60% better performance. Hyundai said it will deploy Boston Dynamics’ Atlas robots at its Georgia plant from 2028.
Seagate stock (STX) slips in premarket after 14% jump as Nvidia CES storage push reshapes AI trade

Seagate stock (STX) slips in premarket after 14% jump as Nvidia CES storage push reshapes AI trade

Seagate shares fell 1.3% to $326 in premarket trading Wednesday after surging 14% Tuesday to $330.42, hitting a record high. The move followed Nvidia CEO Jensen Huang’s CES remarks on new AI storage technology, which also sent SanDisk, Western Digital, and Micron to all-time highs. CEO Dave Mosley sold 20,000 shares Jan. 2 under a pre-arranged plan, SEC filings show.
Microchip stock leaps on upbeat sales update as traders eye Feb. 5 results

Microchip stock leaps on upbeat sales update as traders eye Feb. 5 results

Microchip Technology shares surged 11.6% to $74.87 after the company raised its fiscal third-quarter sales outlook to $1.185 billion, above previous guidance. CEO Steve Sanghi cited strong bookings and a broad-based recovery. The update boosted shares of Texas Instruments and NXP Semiconductors. Investors await Microchip’s full results and March-quarter guidance on Feb. 5.
BitMine Immersion Technologies (BMNR) stock slides after $14.2B crypto stash update as share vote nears

BitMine Immersion Technologies (BMNR) stock slides after $14.2B crypto stash update as share vote nears

BitMine Immersion Technologies shares fell 3.1% to $32.33 Tuesday after reporting $14.2 billion in crypto and cash holdings, including 4.14 million ether. Shareholders will vote Jan. 15 on raising authorized shares. MSCI said it will not exclude “digital asset treasury companies” like BitMine from its benchmarks for now. Cantor Fitzgerald began coverage with an Overweight rating and a $39 target.
Vertiv stock (VRT) whipsaws after Nvidia CES cooling claim; earnings next in focus

Vertiv stock (VRT) whipsaws after Nvidia CES cooling claim; earnings next in focus

Vertiv shares closed up 0.6% at $174.95 after dropping as much as 6.6% intraday, following Nvidia CEO Jensen Huang’s comment that new Rubin chips need “no water chillers.” Johnson Controls fell 6.2% and Trane dropped 2.5%. Barclays said Vertiv and nVent are better positioned in liquid and precision cooling. About 7.8 million Vertiv shares traded.
Johnson Controls (JCI) stock slides 6% after Nvidia’s “no water chillers” line jolts data-center cooling trade

Johnson Controls (JCI) stock slides 6% after Nvidia’s “no water chillers” line jolts data-center cooling trade

Johnson Controls shares fell 6.2% to $113.95 after Nvidia CEO Jensen Huang said new chips could sharply reduce data-center cooling needs. Trane dropped 2.5% and Carrier slipped 0.5%. Barclays estimates data centers are a low-double-digit share of Johnson Controls’ sales. Investors now await CES updates, U.S. jobs data, and Johnson Controls’ Feb. 4 results.
Applied Materials stock jumps to a fresh 52-week high as CES AI talk lifts chip-equipment shares

Applied Materials stock jumps to a fresh 52-week high as CES AI talk lifts chip-equipment shares

Applied Materials shares jumped 4.1% to a record $296.01 Tuesday as chip-equipment stocks rallied on renewed AI optimism and CES headlines. The Philadelphia Semiconductor Index hit an all-time high. Peers Lam Research, KLA, and ASML also advanced. Investors await U.S. labor data and Applied Materials’ earnings report on Feb. 12.
AST SpaceMobile stock jumps on AT&T satellite-to-phone beta plan — what investors watch next

AST SpaceMobile stock jumps on AT&T satellite-to-phone beta plan — what investors watch next

AST SpaceMobile shares jumped 7.2% Tuesday before slipping 1.8% to $95.75 after hours. Investors tracked AT&T’s plan to begin a limited satellite-to-phone beta in the first half of 2026. Options activity surged, with calls outpacing puts and implied volatility rising. The next BlueBird satellite launch and March earnings window remain in focus.
Walmart stock (WMT) rises as Walmart Connect rolls out ad assistant ahead of earnings

Walmart stock (WMT) rises as Walmart Connect rolls out ad assistant ahead of earnings

Walmart shares rose 1.5% to $114.34 in after-hours trading Tuesday after its advertising unit unveiled a new AI assistant for Sponsored Search campaigns, now in beta. The move comes ahead of Walmart’s Feb. 19 earnings report. Director Timothy Patrick Flynn received 337 stock units at $111.41 as deferred compensation, a regulatory filing showed.
1 86 87 88 89 90 205

Stock Market Today

  • Lean Hog Futures Edge Higher Amid Mixed USDA Reports
    April 27, 2026, 3:45 PM EDT. Lean hog futures gained modestly on Monday, with front-month contracts rising by 0.05 cents. The USDA's national base hog price fell 28 cents to $90.32, while the CME Lean Hog Index ticked up slightly to $91.44. Pork stocks increased slightly year-over-year, according to Cold Storage data. Managed money reduced their net long positions in lean hog futures and options by 22,296 contracts as of April 21. USDA reported a pork carcass cutout value rise of 68 cents to $100.29 per hundredweight, with loin and picnic primals declining. Federally inspected hog slaughter last week totaled 2.469 million head, down weekly but higher than last year. Futures for May, June, and July hog contracts posted small gains amid these mixed signals.

Latest article

Intellia Therapeutics CRISPR Trial Win Puts One-Time HAE Drug On FDA Track

Intellia Therapeutics CRISPR Trial Win Puts One-Time HAE Drug On FDA Track

27 April 2026
Intellia Therapeutics reported its CRISPR drug lonvo-z cut hereditary angioedema attacks by 87% versus placebo in a late-stage trial, with 62% of treated patients attack- and therapy-free over six months. The company has started a rolling U.S. approval application. No serious adverse events were reported. Intellia shares fell 0.9% to $13.51 after initial gains.
U.S. Energy Corp Stock Jumps as $285 Helium Deal Gives Big Sky a Buyer

U.S. Energy Corp Stock Jumps as $285 Helium Deal Gives Big Sky a Buyer

27 April 2026
U.S. Energy Corp. signed a five-year helium sales deal with an unnamed global industrial gas company, securing a buyer for output from its planned Big Sky Carbon Hub in Montana. The contract covers up to 1.2 million cubic feet a month at a fixed $285 per thousand cubic feet, with inflation adjustments starting March 2028. U.S. Energy shares rose 20.8% to $1.12 on heavy volume. The agreement is “take-or-pay,” with the buyer handling pickup at the plant.
Veradermics Stock Jumps After VDPHL01 Hair-Loss Pill Hits Trial Goals

Veradermics Stock Jumps After VDPHL01 Hair-Loss Pill Hits Trial Goals

27 April 2026
Veradermics shares rose 40% Monday after its oral hair-loss drug VDPHL01 met all main goals in a Phase 2/3 trial of 519 men. Patients taking the drug saw average hair count increases of 30.3 to 33.0 hairs per square centimeter over six months, compared to 7.3 for placebo. No treatment-related serious or heart-related adverse events were reported.
Go toTop